Moreover, several other mediators of the immune response have been investigated, such as IFN-γ, which has a pleiotropic activity on the immune system and can alter the expression of PD-L1 [10], albeit its role in tumor progression and immunotherapy response is still controversial [11]. This evidence concerns the gene IFNG and neoplasm.